Product Under Development

Glucagon is a peptide hormone, produced by alpha cells of the pancreas. It works to raise the concentration of glucose in the bloodstream. Its effect is opposite that of insulin. It is used for Hypoglycemia.
Icatibant is a peptidomimetic drug consisting of ten amino acids, which is a selective and specific antagonist of bradykinin B2 receptors. It has been approved by the European Commission for the symptomatic treatment of acute attacks of hereditary angioedema (HAE) in adults
Liraglutide is a long-acting glucagon-like peptide-1 receptor agonist, binding to the same receptors as does the endogenous metabolic hormone GLP-1 that stimulates insulin secretion. It is an injectable drug developed for the treatment of type 2 diabetes
Semaglutide is a once-daily glucagon-like peptide-1 analog As a glucagon-like peptide-1 receptor agonist, it lowers the blood sugar level by increasing the production of insulin. It was FDA approved on December 5, 2017.
Tesamorelin is a synthetic form of growth-hormone-releasing hormone which is used in the treatment of HIV-associated lipodystrophy. Tesamorelin injection is used to decrease the amount of extra fat in the stomach area in adults with human immunodeficiency virus (HIV) who have lipodystrophy (increased body fat in certain areas of the body).
Histrelin is a gonadotropin releasing hormone (GnRH) agonist that acts as a potent inhibitor of gonadotropin when administered as an implant that delivers continuous therapeutic doses. It is indicated for the treatment of children with central precocious puberty. It is also potent inhibitor of production of testosterone (in men) and estrogen (in women) and is used predominantly to treat advanced prostate cancer.
Lanreotide is a synthetic analogue of somatostatin, It is used in the treatment of acromegaly, due to both pituitary and non-pituitary growth hormone-secreting tumors, and the management of symptoms caused by neuroendocrine tumors, particularly carcinoid tumors and VIPomas. It is used for polycystic liver disease.
Plecanatide is a drug approved by the FDA for the treatment of chronic idiopathic constipation (CIC) and irritable bowel syndrome with constipation. It is an agonist of guanylate cyclase-C. It increases intestinal transit and fluid through a buildup of cGMP
Sincalide is the 8-amino acid C-terminal fragment of cholecystokinin, and known as CCK-8, Sincalide is used to help diagnose disorders of the gallbladder or pancreas. It is also used to speed up digestion of barium, a contrast agent, given in preparation for x-ray examination of the intestines.